Anti-inflammatory diet (DI)
Behavioral12-week personalized dietary advice based on the Dutch Dietary Guidelines under the guidance of a dietician.
Other names: DI
NCT Number: NCT06332560
The goal of this clinical trial is to investigate the effect of an anti-inflammatory diet and cognitive behavioral therapy (CBT) on pain symptoms, health related quality of life and the effect on inflammatory characteristics in serum and menstruum samples as well as the effect on the gut and vaginal microbiome in women with endometriosis. In addition, we want to investigate the differences in stress (measured by hair cortisol levels), inflammatory markers in peripheral blood, menstrual effluent, and the vaginal and intestinal microbiome between persons without and with endometriosis. Participants will be randomized between standard care (control group), standard care and an anti-inflammatory diet intervention, or standard care, an anti-inflammatory diet intervention and CBT or CBT alone. Participants will follow an anti-inflammatory diet based on the Dutch Dietary Guidelines or CBT or a combination of both interventions for 12 weeks. They will receive personalized dietary advice from a dietician and recipes will be available. cognitive behavioral therapy will be administered in a total of seven individual sessions led by a psychotherapist. The content of these sessions will be psycho-education regarding pain mechanisms (and diet).
Interested in participating?
Request Info17 year and older
Female
Interventional
Not applicable
Jeroen Bosch Hospital (JBZ), 's-Hertogenbosch, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-week personalized dietary advice based on the Dutch Dietary Guidelines under the guidance of a dietician.
Other names: DI
Seven individual sessions led by a psychotherapist. The content of the CBT will be psycho-education regarding pain mechanisms and DI.
Other names: CBT
Time frame: 3 months
The Numerical Rating Scale (NRS) ranges from 0 (no pain) to 10 (unbearable pain), and is the most commonly used subjective measure to assess pain intensity. Patients will score there estimated average pain intensity and there highest pain intensity of the previous 7 days.
Minimum value: 0 Maximum value: 10 Higher score indicates a higher level of pain intensity.
Time frame: 3 months
The Endometriosis Health Profile 30 (EHP-30) is a disease-specific QoL questionnaire which is validated for use in endometriosis patients and measures the impact of the disease on physical, mental and social aspects of life.
The EHP-30 is not a numerical scale.
Time frame: 3 months
The Short Form 36 (SF-36) is a multipurpose, general health survey which is applied to measure QoL on nine different domains: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, emotional well-being, vitality, pain, general health, and health change.
The SF-36 is not a numerical scale.
Time frame: 3 months
High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also Naturel Killer (NK) cells will be analysed. Also in the menstruum, markers for (cluster of differentiation 56) CD56, (cluster of differentiation antigen 16) CD16, (killer immunoglobulin receptors)) KIR and (natural cytotoxicity receptors) NCR, and activation markers such as CD69 will be characterised.
Time frame: 3 months
High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also NK cells will be analysed. Previous studies have described a key role for NK cells in endometriosis. A decreased percentage of NK cells was observed in peritoneal fluid of endometriosis patients compared to HC (Hoogstad-vanEvert et al., 2018 ). For in depth NK cell characterisation we will include markers for CD56, CD16, KIR (killer immunoglobulin receptors) and NCR (natural cytotoxicity receptors), and activation markers such as CD69.
Time frame: 3 months
Analysed with the Olink Proteomics 96 inflammatory panel and Luminex multiplex assay for important soluble factors in endometriosis, i.e. IFNy, TNFα, TNFβ, IL1, IL2, IL6, IL8, IL12 and IL15, VEGF, Granzyme B, and perforin.
Time frame: 3 months
Through 16S sRNA gene profiling the microbiome composition of faecal samples and vaginal swabs will be determined. Vaginal and faecal samples will be stored for later microbiome analysis if the the investigators see clear differences in inflammatory profiles after the dietary intervention.
Time frame: 3 months
Cortisol will be extracted from hair. The researcher will carefully collect a scalp hair sample of at least 0,5 cm thickness and sent these to the laboratory to analyze. The most proximal part represents the most recently grown piece of hair. Hair samples will be cut into a segment corresponding to the 4 cm closest to the scalp, reflecting cortisol secretion over the four months prior to sample collection. Cortisol extraction from hair will be carried out using an enzyme-linked immunoassay (ELISA).
Time frame: 3 months
Diet quality will be assessed by the Eetscore. The Eetscore is a short (Food Frequency Questionnaire) FFQ, developed to assess the Dutch Healthy Diet 2015 (DHD2015) index. The questionnaire is composed of 40 questions assessing the frequency of consumption of food items. From the Eetscore FFQ, a DHD2015-index score can be calculated, indicating the diet quality of an individual.
Ranges from 0 (unhealthy diet) - 160 (healthy diet).
Time frame: 3 months
Sleep quality will be assessed by a self-rated questionnaire called (Pittsburgh sleep quality index) PSQI. This questionnaire contains 19 items, generating scores for seven different components. A general score can be obtained by adding up the scores of the seven components. Currently, PSQI is the most used tool in clinical and research practice assessing sleep quality.
Minimum score: 0. Maximum score: 21. Higher scores indicate worse sleep quality.
Time frame: 3 months
Physical activity level will be assessed in this study to minimise confounding. Participants will fill in the (International Physical Activity Questionnaire Shor Form) IPAQ-SF, which is one of the most widely used self-report questionnaires assessing physical activity. This questionnaire assesses physical activity of the past seven days at four levels of intensity: vigorous, moderate, walking, and sitting.
The IPAQ-SF sum score is expressed in PA Metabolic Equivalent of Task (MET)-minutes per day or week. A higher score corresponds to a physically more strenuous activity.
Time frame: 3 months
Perceived stress will be measured using the Perceived Stress Scale (PSS), a 10-item validated psychological instrument for measuring nonspecific perceived stress. Items are designed to score how unpredictable, uncontrollable, and overloaded respondents find their lives.
Minimum value: 10. Maximum value: 50. Higher score indicates a higher level of perceived stress.
Time frame: 3 months
The Pain anxiety symptom scale (PASS) measures anxiety caused by pain. Questions are asked about feelings of fear of pain, cognitive anxiety, avoidance behaviour, and physiological anxiety symptoms.
Minimum value: 0. Maximum value: 200. Higher score indicates a higher pain anxiety.
Time frame: 3 months
The pain catastrophizing Scale (PCS) measures the degree of pain catastrophizing of the participant by measuring elements of helplessness and pessimism in relation to the ability to cope with the pain experience.
Minimum value: 0. Maximum value: 52. Higher score indicates a higher level of catastrophizing
Time frame: 3 months
The checklist Individual Strength (CIS) is a 20-item questionnaire addressing fatigue, concentration, motivation and activity over the past two weeks.
The CIS is not a numerical scale.
Time frame: At the end of the intervention (3 months), when completed the diet intervention
At the end of the intervention period, participants will evaluate the anti-inflammatory diet with a rating on scale, and several general questions concerning the taste, cost, and feasibility.
Minimum value: 1 Maximum value: 10. Higher scores indicates greater satisfaction with the diet.
Time frame: 3 months
The global level of nucleosomes and the levels of nucleosome containing specific histone post-transcriptional modifications will be analyzed in menstrual effluent and/or K2-EDTA plasma samples from healthy patients (n=50) and from patients in the SC + DI and SC + DI + CBT group. DNA extraction from K2-EDTA plasma samples or from menstrual effluent, and DNA amount quantification and fragments length qualification Analysis of the samples will be performed using Nu.Q® immunoassays according to the instructions of the SME company Volition (Belgium), allowing for the quantification of specific nucleosome structures.
Time frame: 3 months
To measure metabolites, to understand the impact of both interventions on metabolic pathways
Time frame: Baseline
High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also NK cells will be analysed. Previous studies have described a key role for NK cells in endometriosis. A decreased percentage of NK cells was observed in peritoneal fluid of endometriosis patients compared to HC (Hoogstad-vanEvert et al., 2018 ). For in depth NK cell characterisation we will include markers for CD56, CD16, KIR (killer immunoglobulin receptors) and NCR (natural cytotoxicity receptors), and activation markers such as CD69.
Time frame: Baseline
Through 16S sRNA gene profiling the microbiome composition of faecal samples and vaginal swabs will be determined.
Time frame: Baseline
Cortisol will be extracted from hair. The researcher will carefully collect a scalp hair sample of at least 0,5 cm thickness and sent these to the laboratory to analyse. The most proximal part represents the most recently grown piece of hair. Hair samples will be cut into a segment corresponding to the 4 cm closest to the scalp, reflecting cortisol secretion over the four months prior to sample collection. Cortisol extraction from hair will be carried out using an enzyme-linked immunoassay (ELISA) (DRG Instruments GmbH, Marburg, Germany). Analysis of the samples will be performed according to the instructions of the ELISA kit manual at Biopsychology - TU Dresden (Germany).
Contact information is provided by the study sponsor or research team.
Radboud University Medical Center
Other
Pain in Endometriosis And the Relation to Lifestyle: Effectiveness of a Dietary Intervention and Cognitive Behavioral Therapy in Endometriosis-associated Pain
Acronym: PEARL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04481321
Adenomyosis, Endometriosis
Paris, France
View Trial DetailsNCT07728695
Adenomyosis, Adnexal Diseases
Belmont, Massachusetts, United States
View Trial DetailsNCT07205614
Adenomyosis, Dysmenorrhea
Kristiansand, Agder, Norway
View Trial DetailsNCT06864494
Adenomyosis, Endometriosis
Nîmes, France
View Trial Details